CTTHOTCPharmaceutical PreparationsFiscal year ends December 31

CTT PHARMACEUTICAL HOLDINGS, INC.

Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Sep 17, 2026

$0.06−0.00 (-0.17%)

Close on Oct 16, 2026

Market cap: $1.26M
P/E (TTM): –
Dividend yield: –

CTT PHARMACEUTICAL HOLDINGS, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	TTM Q3 2015 2015-09-30	TTM Q2 2015 2015-06-30	TTM Q1 2015 2015-03-31	TTM FY 2014 2014-12-31	TTM Q3 2014 2014-09-30	TTM Q2 2014 2014-06-30	TTM Q1 2014 2014-03-31	TTM FY 2013 2013-12-31	TTM Q3 2013 2013-09-30	TTM Q2 2013 2013-06-30	TTM Q1 2013 2013-03-31	TTM FY 2012 2012-12-31	TTM Q3 2012 2012-09-30	TTM Q2 2012 2012-06-30	TTM Q1 2012 2012-03-31	TTM FY 2011 2011-12-31	TTM Q3 2011 2011-09-30	TTM Q2 2011 2011-06-30	TTM Q1 2011 2011-03-31	TTM FY 2010 2010-12-31
General & Administrative	0.06	0.06	0.05	0.02	0.02	0.00	0.03	0.00	0.10	0.12	0.14	0.16	0.17	0.20	0.36	0.32	0.27	0.45	0.31	0.31
Operating Expenses	1.67	1.37	1.01	0.67	0.05	0.02	0.08	0.02	0.33	0.44	0.57	1.19	1.08	1.07	1.31	0.76	1.13	2.01	1.95	2.07
Operating Income	–	–	–	–	–	0.08	0.04	-0.02	-0.35	-0.44	-0.57	-1.19	-1.08	-1.07	-1.31	-0.76	-1.13	-2.01	-1.95	-2.07
Income from Equity Investments	–	–	–	–	–	–	–	–	–	–	–	0	-0.23	-0.58	-1.26	-1.52	-1.29	-0.94	–	0
Minority Interest in Earnings	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0	–	–	–	-0.50
Net Income	-1.67	-1.37	-1.01	-0.67	-0.05	-0.02	-0.08	-0.02	-0.29	-0.39	-0.36	-1.00	-1.16	-1.49	-2.53	3.74	3.65	3.65	4.73	-1.10
EPS (Basic)(per share)	-0.03	-0.01	-0.01	-0.0025	-0.01	-0.01	-0.01	-0.0006	-0.01	-0.0019	-0.0013	-0.0069	-0.0044	-0.0069	-0.01	0.03	0.03	0.03	0.04	-0.0081
EPS (Diluted)(per share)	-0.03	-0.01	-0.01	-0.0025	-0.01	-0.0006	-0.0013	-0.0006	-0.0013	-0.0019	-0.0013	-0.0069	-0.0044	-0.0069	-0.01	0.03	0.03	0.03	0.04	-0.0081
Shares Outstanding (Basic, Weighted)(shares)	218	217	191	261	161	194	172	239	150	150	150	151	148	146	145	143	142	141	138	136
Shares Outstanding (Diluted, Weighted)(shares)	218	217	191	261	161	194	172	239	150	150	150	151	151	150	148	152	144	142	140	136
EBITDA	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	-0.76	–	–	–	-2.00

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2015

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2014: -91.9%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: –
Price to book: 1.70
Dividend yield: –